{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:31:59Z","timestamp":1791153119988,"version":"4.1.0"},"reference-count":150,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":2825,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.fertnstert.2014.07.1238","type":"journal-article","created":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T20:37:18Z","timestamp":1409085438000},"page":"630-639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Fibroid growth and medical options for treatment"],"prefix":"10.1016","volume":"102","author":[{"given":"Nathalie","family":"Chabbert-Buffet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Esber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2014.07.1238_bib1","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMra1209993","article-title":"Uterine fibroids","volume":"369","author":"Bulun","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib2","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1126\/science.1112063","article-title":"Uterine fibroids: the elephant in the room","volume":"308","author":"Walker","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/molehr\/gat083","article-title":"Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues","volume":"20","author":"Holdsworth-Carson","year":"2014","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1126\/science.150.3692.67","article-title":"Glucose-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas","volume":"150","author":"Linder","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/humupd\/dmt058","article-title":"Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations","volume":"20","author":"Segars","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/aje\/kws585","article-title":"Association of age at menarche with increasing number of fibroids in a cohort of women who underwent standardized ultrasound assessment","volume":"178","author":"Velez Edwards","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib7","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.fertnstert.2006.11.012","article-title":"Polycystic ovary syndrome and risk of uterine leiomyomata","volume":"87","author":"Wise","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib8","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bpobgyn.2008.04.002","article-title":"Incidence, aetiology and epidemiology of uterine fibroids","volume":"22","author":"Okolo","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib9","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1210\/jc.2012-3237","article-title":"Uterine leiomyoma: available medical treatments and new possible therapeutic options","volume":"98","author":"Islam","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejogrb.2010.05.012","article-title":"The burden of uterine fibroids in five European countries","volume":"152","author":"Downes","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib11","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.fertnstert.2011.03.079","article-title":"The FIGO classification of causes of abnormal uterine bleeding in the reproductive years","volume":"95","author":"Munro","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.fertnstert.2013.09.038","article-title":"Clinical characteristics indicating adenomyosis coexisting with leiomyomas: a retrospective, questionnaire-based study","volume":"101","author":"Brucker","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4103\/0974-1208.121421","article-title":"Ultrasound diagnosis of adenomyosis, leiomyoma, or combined with histopathological correlation","volume":"6","author":"Hanafi","year":"2013","journal-title":"J Hum Reprod Sci"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/humrep\/det451","article-title":"Is adenomyosis associated with menorrhagia?","volume":"29","author":"Naftalin","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib15","first-page":"40","article-title":"Frequency of endometriosis and adenomyosis in patients with leiomyomas, gynecologic premalignant, and malignant neoplasias","volume":"40","author":"Nomelini","year":"2013","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib16","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.fertnstert.2008.01.051","article-title":"Fibroids and infertility: an updated systematic review of the evidence","volume":"91","author":"Pritts","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib17","unstructured":"National Institute of Demography of Burkina Faso. Evolution of fertility rates by age category (Table\u00a03). In: Population,\u00a02014."},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1471-0528.2000.tb13225.x","article-title":"Assessment of menstrual blood loss using a pictorial chart: a validation study","volume":"107","author":"Reid","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib19","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/bmj.38376.505382.AE","article-title":"Trends in number of hysterectomies performed in England for menorrhagia: examination of health episode statistics, 1989 to 2002\u20133","volume":"330","author":"Reid","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/IJWH.S51083","article-title":"Uterine fibroids: current perspectives","volume":"6","author":"Khan","year":"2014","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib21","doi-asserted-by":"crossref","first-page":"211.e1","DOI":"10.1016\/j.ajog.2011.12.002","article-title":"The estimated annual cost of uterine leiomyomata in the United States","volume":"206","author":"Cardozo","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/RLI.0b013e3182806904","article-title":"Magnetic resonance imaging-guided focused ultrasound treatment of symptomatic uterine fibroids: impact of technology advancement on ablation volumes in 115 patients","volume":"48","author":"Trumm","year":"2013","journal-title":"Invest Radiol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jmig.2011.12.011","article-title":"Clinical outcome after hydrothermal ablation treatment of menorrhagia in patients with and without submucous myomas","volume":"19","author":"Hachmann-Nielsen","year":"2012","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5468\/ogs.2013.56.6.375","article-title":"Obstetric outcomes after uterine myomectomy: laparoscopic versus laparotomic approach","volume":"56","author":"Kim","year":"2014","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib25","doi-asserted-by":"crossref","first-page":"206829","DOI":"10.1155\/2013\/206829","article-title":"Preoperative hematocrit concentration and the risk of stroke in patients undergoing isolated coronary-artery bypass grafting","volume":"2013","author":"Musallam","year":"2013","journal-title":"Anemia"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib26","first-page":"CD010241","article-title":"Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding","author":"Tan","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-0030-1251475","article-title":"Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women","volume":"28","author":"Malik","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/OGX.0b013e3181d60f93","article-title":"Pathogenesis of benign metastasizing leiomyoma: a review","volume":"65","author":"Awonuga","year":"2010","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib29","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1007\/s00259-011-1851-8","article-title":"Additional value of 16alpha-[18F]fluoro-17beta-oestradiol PET for differential diagnosis between uterine sarcoma and leiomyoma in patients with positive or equivocal findings on [18F]fluorodeoxyglucose PET","volume":"38","author":"Yoshida","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib30","unstructured":"Cancer Research UK. Soft tissue sarcoma incidence statistics. In,\u00a02013."},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib31","doi-asserted-by":"crossref","first-page":"18700","DOI":"10.1073\/pnas.0704472104","article-title":"Side population in human uterine myometrium displays phenotypic and functional characteristics of myometrial stem cells","volume":"104","author":"Ono","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib32","doi-asserted-by":"crossref","first-page":"e36935","DOI":"10.1371\/journal.pone.0036935","article-title":"Role of stem cells in human uterine leiomyoma growth","volume":"7","author":"Ono","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib33","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.fertnstert.2012.04.044","article-title":"Identification and characterization of the human leiomyoma side population as putative tumor-initiating cells","volume":"98","author":"Mas","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib34","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1038\/bjc.2014.138","article-title":"Mutation analysis of components of the mediator kinase module in MED12 mutation\u2013negative uterine leiomyomas","volume":"110","author":"Makinen","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib35","doi-asserted-by":"crossref","first-page":"474.e1","DOI":"10.1016\/j.ajog.2007.11.057","article-title":"Mechanical homeostasis is altered in uterine leiomyoma","volume":"198","author":"Rogers","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib36","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1210\/er.2012-1043","article-title":"Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer","volume":"34","author":"Kim","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib38","first-page":"900","article-title":"Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle","volume":"79","author":"Stewart","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib39","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/humrep\/den025","article-title":"Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer","volume":"23","author":"Morikawa","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2133.2005.06678.x","article-title":"Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer","volume":"153","author":"Alam","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib41","doi-asserted-by":"crossref","first-page":"e33284","DOI":"10.1371\/journal.pone.0033284","article-title":"Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma","volume":"7","author":"Navarro","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib42","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/1541-7786.MCR-11-0605","article-title":"Environmental estrogens differentially engage the histone methyltransferase EZH2 to increase risk of uterine tumorigenesis","volume":"10","author":"Greathouse","year":"2012","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib43","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.fertnstert.2007.05.074","article-title":"Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium","volume":"89","author":"Marsh","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ygeno.2012.03.003","article-title":"Characterization of the uterine leiomyoma microRNAome by deep sequencing","volume":"99","author":"Georgieva","year":"2012","journal-title":"Genomics"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1302736","article-title":"Characterization of uterine leiomyomas by whole-genome sequencing","volume":"369","author":"Mehine","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib46","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.cct.2007.11.003","article-title":"A comparison of methods and results in recruiting white and black women into reproductive studies: the MMC-PSU Cooperative Center on Reproduction Experience","volume":"29","author":"Sweet","year":"2008","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib47","doi-asserted-by":"crossref","first-page":"19887","DOI":"10.1073\/pnas.0808188105","article-title":"Growth of uterine leiomyomata among premenopausal black and white women","volume":"105","author":"Peddada","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib48","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/humrep\/des046","article-title":"Hypertension and risk of uterine leiomyomata in US black women","volume":"27","author":"Radin","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/aje\/kwh016","article-title":"Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study","volume":"159","author":"Wise","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib50","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/01.ede.0000158742.11877.99","article-title":"Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women","volume":"16","author":"Wise","year":"2005","journal-title":"Epidemiology"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib51","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/01.AOG.0000154161.03418.e3","article-title":"Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study","volume":"105","author":"Wise","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib52","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.annepidem.2012.09.006","article-title":"Association of intrauterine and early life factors with uterine leiomyomata in black women","volume":"22","author":"Wise","year":"2012","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib53","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.maturitas.2008.07.001","article-title":"The catechol-O-methyltransferase (COMT) gene polymorphism and prevalence of uterine fibroids","volume":"60","author":"de Oliveira","year":"2008","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib54","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1933719106298687","article-title":"Val153Met polymorphism of catechol-O-methyltransferase and prevalence of uterine leiomyomata","volume":"14","author":"Gooden","year":"2007","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib55","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-0033-1348896","article-title":"Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma","volume":"31","author":"Catherino","year":"2013","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib56","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1177\/1933719111408111","article-title":"Adipocytes enhance the proliferation of human leiomyoma cells via TNF-alpha proinflammatory cytokine","volume":"18","author":"Nair","year":"2011","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/09513590.2010.487605","article-title":"Antiproliferative effect of adiponectin on rat uterine leiomyoma ELT-3 cells","volume":"27","author":"Wakabayashi","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib58","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1289\/ehp.0901543","article-title":"Association of exposure to phthalates with endometriosis and uterine leiomyomata: findings from NHANES, 1999\u20132004","volume":"118","author":"Weuve","year":"2010","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib59","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.reprotox.2005.01.002","article-title":"Prenatal diethylstilbestrol (DES) exposure is associated with uterine leiomyoma development","volume":"20","author":"Baird","year":"2005","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib60","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/01926230290105839","article-title":"Characterization of uterine leiomyomas in CD-1 mice following developmental exposure to diethylstilbestrol (DES)","volume":"30","author":"Newbold","year":"2002","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib61","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.fertnstert.2004.07.922","article-title":"The guinea pig model for uterine leiomyomata: gene-hormone interaction?","volume":"82","author":"McDonough","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib62","first-page":"736","article-title":"Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture","volume":"78","author":"Bulun","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib63","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.fertnstert.2008.09.064","article-title":"A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status","volume":"93","author":"Parsanezhad","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib64","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ogc.2005.12.001","article-title":"Steroid hormones and leiomyomas","volume":"33","author":"Marsh","year":"2006","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib65","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.fertnstert.2007.09.019","article-title":"Estrogen receptor alpha and beta in uterine fibroids: a basis for altered estrogen responsiveness","volume":"90","author":"Bakas","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib66","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000330700","article-title":"Protein expression of estrogen receptors alpha and beta and aromatase in myometrium and uterine leiomyoma","volume":"73","author":"Grings","year":"2012","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib67","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2174\/1566524043359656","article-title":"The Eker rat: establishing a genetic paradigm linking renal cell carcinoma and uterine leiomyoma","volume":"4","author":"Cook","year":"2004","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib68","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004347-198506000-00001","article-title":"The effect of progestins on the mitotic activity of uterine fibromyomas","volume":"4","author":"Tiltman","year":"1985","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib69","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000292738","article-title":"Proliferative activity of human uterine leiomyoma cells as measured by automatic image analysis","volume":"34","author":"Lamminen","year":"1992","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib70","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0301-2115(01)00588-7","article-title":"Effect of different doses of progestin on uterine leiomyomas in postmenopausal women","volume":"102","author":"Palomba","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib71","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/oxfordjournals.humrep.a137643","article-title":"Potential role for medroxyprogesterone acetate as an adjunct to goserelin (Zoladex) in the medical management of uterine fibroids","volume":"7","author":"West","year":"1992","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib72","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/oxfordjournals.humrep.a138762","article-title":"Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin \u201cadd-back\u201d for 2 years","volume":"9","author":"Friedman","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib73","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.fertnstert.2011.08.021","article-title":"Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety","volume":"96","author":"Bouchard","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib74","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib75","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib76","first-page":"291","article-title":"The A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single gene","volume":"54","author":"Giangrande","year":"1999","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib77","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00404-012-2245-2","article-title":"Gene and protein expression of progesterone receptor isoforms A and B, p53 and p21 in myometrium and uterine leiomyoma","volume":"286","author":"Lora","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib78","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1349-7006.2001.tb01095.x","article-title":"Progesterone receptor A and B isoforms in the human breast and its disorders","volume":"92","author":"Ariga","year":"2001","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib79","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1210\/jc.2003-031111","article-title":"Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium","volume":"89","author":"Arnett-Mansfield","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib80","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.repbio.2013.09.001","article-title":"The putative roles of nuclear and membrane-bound progesterone receptors in the female reproductive tract","volume":"13","author":"Kowalik","year":"2013","journal-title":"Reprod Biol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib81","doi-asserted-by":"crossref","first-page":"E390","DOI":"10.1210\/jc.2013-2008","article-title":"Expression of a mitochondrial progesterone receptor (PR-M) in leiomyomata and association with increased mitochondrial membrane potential","volume":"99","author":"Feng","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib82","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-0030-1251476","article-title":"Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder","volume":"28","author":"Chegini","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib83","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/humupd\/dmr031","article-title":"Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications","volume":"17","author":"Ciarmela","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib84","doi-asserted-by":"crossref","first-page":"17053","DOI":"10.1073\/pnas.1313650110","article-title":"Paracrine activation of WNT\/beta-catenin pathway in uterine leiomyoma stem cells promotes tumor growth","volume":"110","author":"Ono","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib85","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.acthis.2010.01.001","article-title":"Immunolocalization of VEGF, VEGF receptors, EGF-R and Ki-67 in leiomyoma, cellular leiomyoma and leiomyosarcoma","volume":"113","author":"Sanci","year":"2010","journal-title":"Acta Histochem"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib86","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.fertnstert.2013.03.007","article-title":"Complex networks of multiple factors in the pathogenesis of uterine leiomyoma","volume":"100","author":"Islam","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib87","first-page":"CD007692","article-title":"Danazol for uterine fibroids","author":"Ke","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib88","first-page":"CD008994","article-title":"Progestogens or progestogen-releasing intrauterine systems for uterine fibroids","author":"Sangkomkamhang","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2014.07.1238_bib89","first-page":"1120","article-title":"Current and future medical treatments for menometrorrhagia during the premenopause","volume":"27","author":"Bouchard","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib90","first-page":"CD000547","article-title":"Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids","author":"Lethaby","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib91","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bpobgyn.2007.07.010","article-title":"An evidence-based approach to hormonal therapies for premenopausal women with fibroids","volume":"22","author":"Lethaby","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib92","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1056\/NEJMoa1204724","article-title":"Levonorgestrel intrauterine system versus medical therapy for menorrhagia","volume":"368","author":"Gupta","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib93","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3109\/09513590.2013.769517","article-title":"The levonorgestrel-releasing intrauterine system: its effect on the number of hysterectomies performed in perimenopausal women with uterine fibroids","volume":"29","author":"Machado","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib94","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.contraception.2010.02.011","article-title":"Intrauterine device use among women with uterine fibroids: a systematic review","volume":"82","author":"Zapata","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib95","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.fertnstert.2004.12.058","article-title":"Antiproliferative and proapoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women","volume":"84","author":"Palomba","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib96","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/humrep\/17.12.3213","article-title":"Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial","volume":"17","author":"Palomba","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib97","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.fertnstert.2004.03.009","article-title":"Does raloxifene inhibit the growth of uterine fibroids?","volume":"81","author":"Palomba","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib98","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/humrep\/del515","article-title":"Concentration-dependent effects of a selective estrogen receptor modulator raloxifene on proliferation and apoptosis in human uterine leiomyoma cells cultured in\u00a0vitro","volume":"22","author":"Liu","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib99","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0140-6736(13)60140-3","article-title":"Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data","volume":"381","author":"Cuzick","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib100","first-page":"CD005287","article-title":"Selective estrogen receptor modulators (SERMs) for uterine leiomyomas","author":"Deng","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib101","first-page":"9","article-title":"Selective estrogen receptor modulator and selective progesterone receptor modulator: therapeutic efficacy in the treatment of uterine leiomyoma","volume":"32","author":"Ohara","year":"2005","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib102","first-page":"CD009505","article-title":"Aromatase inhibitors for uterine fibroids","author":"Song","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib103","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.fertnstert.2007.11.006","article-title":"Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients","volume":"91","author":"Hilario","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib104","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/107155760301000105","article-title":"Gonadotropin releasing hormone analogue therapy alters signal transduction pathways involving mitogen-activated protein and focal adhesion kinases in leiomyoma","volume":"10","author":"Chegini","year":"2003","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jsgi.2004.10.008","article-title":"Clinical response, vascular change, and angiogenesis in gonadotropin-releasing hormone analogue\u2013treated women with uterine myomas","volume":"12","author":"di Lieto","year":"2005","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib106","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1028-4559(09)60273-4","article-title":"Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas","volume":"48","author":"Wang","year":"2009","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib107","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1210\/en.2004-1384","article-title":"Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy","volume":"146","author":"Luo","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib108","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/humupd\/dmi002","article-title":"Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications","volume":"11","author":"Chabbert-Buffet","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib109","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1210\/jc.2006-0898","volume":"92","author":"Sasaki","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/molehr\/gan004","article-title":"Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells","volume":"14","author":"Xu","year":"2008","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib111","doi-asserted-by":"crossref","first-page":"E1002","DOI":"10.1152\/ajpendo.00210.2007","article-title":"Selective progesterone receptor modulator asoprisnil induces endoplasmic reticulum stress in cultured human uterine leiomyoma cells","volume":"293","author":"Xu","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib112","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1210\/jc.2005-2379","article-title":"A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells","volume":"91","author":"Chen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib113","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1016\/j.fertnstert.2009.11.031","article-title":"The selective progesterone receptor modulator CDB4124 inhibits proliferation and induces apoptosis in uterine leiomyoma cells","volume":"93","author":"Luo","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib114","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/j.contraception.2007.01.025","article-title":"Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas","volume":"75","author":"Maruo","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib115","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/humrep\/del035","article-title":"A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells","volume":"21","author":"Wang","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib116","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/humrep\/del159","article-title":"Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells","volume":"21","author":"Xu","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib117","doi-asserted-by":"crossref","first-page":"e80114","DOI":"10.1371\/journal.pone.0080114","article-title":"GSTM1 gene expression correlates to leiomyoma volume regression in response to mifepristone treatment","volume":"8","author":"Engman","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib118","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0015-0282(16)56214-1","article-title":"Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist","volume":"60","author":"Kettel","year":"1993","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib119","first-page":"513","article-title":"Regression of uterine leiomyomata in response to the antiprogesterone RU 486","volume":"76","author":"Murphy","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0015-0282(16)57678-X","article-title":"Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect","volume":"64","author":"Murphy","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib121","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"Long-term treatment of uterine fibroids with ulipristal acetate","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib122","first-page":"404","article-title":"Molecule of the month: asoprisnil","volume":"18","year":"2005","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib123","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.fertnstert.2006.11.094","article-title":"A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata","volume":"87","author":"Chwalisz","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib124","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2010.09.059","article-title":"Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study","volume":"95","author":"Nieman","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib125","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/humrep\/dep100","article-title":"Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial","volume":"24","author":"Engman","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib126","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1210\/jc.2008-1104","article-title":"Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy","volume":"93","author":"Wilkens","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib127","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/AOG.0b013e3181705d0e","article-title":"CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial","volume":"111","author":"Levens","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib128","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejogrb.2009.06.004","article-title":"Open-label study of ultra low-dose mifepristone for the treatment of uterine leiomyomata","volume":"146","author":"Eisinger","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib129","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/01.AOG.0000243776.23391.7b","article-title":"Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial","volume":"108","author":"Fiscella","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijgo.2009.11.019","article-title":"Improved quality of life is partly explained by fewer symptoms after treatment of fibroids with mifepristone","volume":"109","author":"Feng","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib131","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jmig.2005.01.022","article-title":"Twelve-month safety and efficacy of low-dose mifepristone for uterine myomas","volume":"12","author":"Eisinger","year":"2005","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib132","unstructured":"Critchley HO. Three perspectives on progestins: clinical research perspective. Endocr News 2012;February:27\u201330."},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib133","unstructured":"Patlak M. Focus on fibroids. Endocr News 2011;December:32\u20135."},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib134","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.humpath.2010.11.003","article-title":"Distinguishing features of endometrial pathology after exposure to the progesterone receptor modulator mifepristone","volume":"42","author":"Fiscella","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib135","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/modpathol.2008.19","article-title":"The spectrum of endometrial pathology induced by progesterone receptor modulators","volume":"21","author":"Mutter","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib136","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PGP.0b013e318251035b","article-title":"Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate","volume":"31","author":"Williams","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib137","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.fertnstert.2009.08.065","article-title":"Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells","volume":"94","author":"Zhang","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib138","doi-asserted-by":"crossref","first-page":"289.e1","DOI":"10.1016\/j.ajog.2009.10.885","article-title":"Green tea extract inhibits proliferation of uterine leiomyoma cells in\u00a0vitro and in nude mice","volume":"202","author":"Zhang","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib139","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1210\/jcem.83.1.4503","article-title":"Pirfenidone: a novel pharmacological agent that inhibits leiomyoma cell proliferation and collagen production","volume":"83","author":"Lee","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib140","doi-asserted-by":"crossref","first-page":"E1374","DOI":"10.1210\/jc.2013-1777","article-title":"Vitamin D status in women with uterine leiomyomas","volume":"98","author":"Paffoni","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib141","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/EDE.0b013e31828acca0","article-title":"Vitamin D and the risk of uterine fibroids","volume":"24","author":"Baird","year":"2013","journal-title":"Epidemiology"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib142","doi-asserted-by":"crossref","first-page":"E754","DOI":"10.1210\/jc.2010-2131","article-title":"1,25-Dihydroxyvitamin D3 reduces TGF-beta3\u2013induced fibrosis-related gene expression in human uterine leiomyoma cells","volume":"96","author":"Halder","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib143","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1095\/biolreprod.113.107714","article-title":"1,25-Dihydroxyvitamin D3 reduces extracellular matrix\u2013associated protein expression in human uterine fibroid cells","volume":"89","author":"Halder","year":"2013","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib144","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/humrep\/det265","article-title":"Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells","volume":"28","author":"Halder","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib145","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.fertnstert.2008.02.136","article-title":"Vitamin D inhibits myometrial and leiomyoma cell proliferation in\u00a0vitro","volume":"91","author":"Blauer","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib146","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1095\/biolreprod.111.098145","article-title":"1,25-Dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model","volume":"86","author":"Halder","year":"2012","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib147","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1210\/jcem-70-4-1055","article-title":"Bone mass reduction after estrogen deprivation by long-acting gonadotropin-releasing hormone agonists and its relation to pretreatment serum concentrations of 1,25-dihydroxyvitamin D3","volume":"70","author":"Scharla","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib148","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/oxfordjournals.humrep.a136912","article-title":"Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyoma","volume":"4","author":"Waibel-Treber","year":"1989","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib149","first-page":"CD005355","article-title":"Interventions to reduce haemorrhage during myomectomy for fibroids","author":"Kongnyuy","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2014.07.1238_bib150","first-page":"243","article-title":"Low-dose mifepristone for uterine leiomyomata","volume":"101","author":"Eisinger","year":"2003","journal-title":"Obstet Gynecol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028214018652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028214018652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:27:04Z","timestamp":1771435624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028214018652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":150,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0015028214018652"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2014.07.1238","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroid growth and medical options for treatment","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2014.07.1238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}